连续大动脉流量增大:一项对血液动力学和脏反应的试点研究,用于在不补偿性心力衰竭中进行新的皮肤间干预
Marvin A Konstam1, Barbara Czerska, Michael Böhm
1Tufts-New England Medical Center, Tufts University, Boston, MA, USA. MKonstam@tufts-nemc.org
Circulation
|November 9, 2005
概括
连续大动脉流量增大 (CAFA) 改善了血液动力学和降低了心力衰竭患者的血清肌素,这些患者对药物治疗没有反应. 这种新的方法对管理晚期心力衰竭恶化表现有前途.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 医疗器械 医疗器械
背景情况:
- 降低大动脉流量可以引发负面的血管和脏反应.
- 心力衰竭动物模型表明,连续大动脉流量增大 (CAFA) 改善了血液动力学,并卸载了心室.
- CAFA提出了一种潜在的新疗法,用于对标准医疗治疗耐药的心力衰竭恶化.
研究的目的:
- 评估持续大动脉流量增强 (CAFA) 在患有心力衰竭恶化和持续血液动力学障碍的患者的疗效.
- 评估CAFA对血液动力学参数和功能的影响.
主要方法:
- 一项涉及欧洲和美国24名心力衰竭恶化患者的研究.
- 使用Cancion系统 (通过皮肤或手术插入) 实现CAFA,以增加大动脉流量.
- 在CAFA治疗期间和之后监测血液动力学参数和血清肌水平.
主要成果:
- 在CAFA启动后1小时内观察到血液动力学改善.
- 系统性血管阻力和肺毛细血管压力显著降低.
- 心脏指数增加,血清肌素呈现下降趋势,表明潜在的益.
结论:
- 在心力衰竭患者中,CAFA有效地改善了血液动力学和降低了血清肌素,尽管医疗治疗,但心力衰竭患者的疾病持续存在.
- 对于心力衰竭患者来说,CAFA成为一种有前途的新疗法,对传统疗法反应不足.
- 随机对照试验的进一步调查正在进行中,以探索CAFA的临床影响.
相关概念视频
01:17Aortic Regurgitation IV: Nursing Management
457
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
457
01:29Heart Failure II: Pathophysiology
2.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
01:22Heart Failure VI: Adjunct Therapies
635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635